Trump Proposes ‘Historic’ Rule to Allow Price Reductions on Drug Imports

Reporter

12/18/2019|Updated: 12/18/2019

President Donald Trump, along with the Department of Health and Human Services and Food and Drug Administration, released a notice of proposed rulemaking and draft guidance on Dec. 18 that when finalized would allow the importation of certain drugs to ensure price regulation.

The notice of proposed rulemaking (NPRM) and the draft guidance are now open to public comments after being published on the Federal Register.

Venus Upadhayaya

Reporter

Venus Upadhayaya reports on India, China, and the Global South. Her traditional area of expertise is in Indian and South Asian geopolitics. Community media, sustainable development, and leadership remain her other areas of interest.

Author’s Selected Articles

Trump Proposes ‘Historic’ Rule to Allow Price Reductions on Drug Imports

China’s Footprint Is Clear in Kashmir Crisis, Analysts Say

Taiwan’s Tougher China Stance Should Bolster Support From Other Nations: Experts

On the Brink of a Multipolar World, India’s Grand Strategy Is Largely Defined by China, Analysts Say

CCP–Cook Islands Deal Raises Concerns for New Zealand, US, Australia